Patients with systemic lupus erythematosus (SLE) have a higher risk of myocardial involvement, which can result in ventricular dysfunction. The aim of our study was to estimate potential relationship between exercise capacity assessed by six minute walk test (6MWT) and echocardiographic parameters of left and right ventricular function in SLE patients.
Methods
We prospectively studied 66 SLE patients (57 F, age 44 (20–75) years) and 27 age matched healthy subjects. In addition to routine evaluation, 6MWT and transthoracic echocardiography including LV diastolic dysfunction parameters (E/A, E/É) were performed.
Results
While E/A was similar in both groups, E/E’ was higher in patients with SLE than in controls, 7.5 (4–22) vs 6.8 (1.6–9.4), p = 0.018. The mean 6MWT distance was significantly shorter in SLE (561.6 ± 150.7 vs 682.6 ± 98.1 m, p < 0.002). Among SLE patients only 53 (80.3%) were capable to walk at least 450 m, while in controls 27 (100%) (p = 0.013). We observed significant correlations between 6MWT distance and SLICC/ACR-DI (rho=−0.44, p < 0.001), E/A (rho = 0.30, p = 0.004), E/E’ (rho=−0.36, p < 0.001) in SLE patients. Univariable logistic regression models revealed that SLICC/ACR-DI, E/E’, tricuspid regurgitant peak gradient (TRPG), and right ventricular systolic pressure (RVSP) were associated with 6MWT distance lower than < 450 m. ROC curves shown high predictive value of E/E’ ratio, TRPG, RVSP in the prediction for 6MWT distance < 450 m.
Conclusion
Impaired exercise tolerance seems to result mainly from the severity of SLE and LV diastolic dysfunction.
Fors NievesCEIzmirlyPM.Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep2016;
18: 21.
2.
CrowsonCSMattesonELMyasoedovaE, et al.
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum2011;
63: 633–639.
3.
BartelsCMBuhrKAGoldbergJW, et al.
Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol2014;
41: 680–687.
4.
BengtssonCOhmanMLNivedORantapaa DahlqvistS.Cardiovascular event in systemic lupus erythematosus in Northern Sweden: incidence and predictors in a 7-year follow-up study. Lupus2012;
21: 452–459.
5.
HesselvigJHAhlehoffODreyerLGislasonGKofoedK.Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Lupus2017;
26: 48–53.
6.
PrasadMHermannJGabrielSE, et al.
Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol2015;
12: 168–176.
Bourre-TessierJUrowitzMBClarkeAE, et al.
Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care Res2015;
67: 128–135.
9.
BieniasPCiurzyńskiMChrzanowskaA, et al.
Attenuated post-exercise heart rate recovery in patients with systemic lupus erythematosus: the role of disease severity and beta-blocker treatment. Lupus2018;
27: 217–224.
10.
ShangQYipGWTamLS, et al.
SLICC/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus. Lupus2012;
21: 1057–1062.
11.
KimCHAl-KindiSGJandaliBAskariADZachariasMOliveiraGH.Incidence and risk of heart failure in systemic lupus erythematosus. Heart2017;
103: 227–233.
12.
HochbergMC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997;
40: 1725.
13.
GladmanDGinzlerEGoldsmithC, et al.
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996;
39: 363–369.
14.
GalieNHumbertMVachieryJL, et al.; ESC Scientific Document Group.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J2016;
37: 67–119.
15.
LangRMBadanoLPMor-AviV, et al.
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging2015;
16: 233–270.
16.
NaguehSFAppletonCPGillebertTC, et al.
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr2009;
10: 165–193.
17.
NaguehSFSmisethOAAppletonCP, et al.; Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Liège, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri.
Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging2016;
17: 1321–1360.
18.
KendrickKRBaxiSCSmithRM.Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs2000;
26: 216–222.
19.
ATS statement:Guidelines for the six-minute walk test. Am J Respir Crit Care Med2002;
166: 111–117.
20.
DeganoBSitbonOSavaleL, et al.
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis. Chest2010;
137: 1297–1303.
21.
IrzykKBieniasPKostrubiecM, et al.
Six-minute walk test reflects neurohormonal activation and right ventricular function in systemic sclerosis patients. Clin Exp Rheumatol2013;
31: 18–23.
22.
MiyamotoSNagayaNSatohT, et al.
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med2000;
161: 487–492.
23.
BalsamoSNascimento DdaCTibanaRAde SantanaFSda MotaLMDos Santos-NetoLL.The quality of life of patients with lupus erythematosus influences cardiovascular capacity in 6-minute walk test. Rev Bras Reumatol2013;
53: 75–87.
24.
KozoraEZellJSwigrisJ, et al.
Cardiopulmonary correlates of cognition in systemic lupus erythematosus. Lupus2015;
24: 164–173.
25.
RoldanCAAlomariIBAwadK, et al.
Aortic stiffness is associated with left ventricular diastolic dysfunction in systemic lupus erythematosus: a controlled transesophageal echocardiographic study. Clin Cardiol2014;
37: 83–90.
26.
ChenJTangYZhuMXuA.Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis. Clin Rheumatol2016;
35: 2437–2448.
27.
ElnadyBMAbdelghafarASKhalikES, et al.
The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients. Eur J Rheumatol2016;
3: 109–117.
28.
LeonePCiccoSPreteM, et al.
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease. Clin Exp Med2020;
20: 11–19.
29.
ChinCWChinCYNgMX, et al.
Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus. Rheumatol Int2014;
34: 1281–1285.
30.
WislowskaMDereńDKochmańskiMSypułaSRozbickaJ.Systolic and diastolic heart function in SLE patients. Rheumatol Int2009;
29: 1469–1476.
